Home | Browse | Search | Credits | About
Register | User Area | DL-Harvest | Help
DLIST

Tuberculosis Research in India and China: From Bibliometrics to Research Policy

Arunachalam, Subbiah and Gunasekaran, Subbiah (2002) Tuberculosis Research in India and China: From Bibliometrics to Research Policy. Current Science 82(8):pp. 933-947.

Full text available as:
PDF - Requires Adobe Acrobat Reader or other PDF viewer.

Abstract

India and China lead the world in the incidence of tuberculosis (TB), accounting for 23% and 17% respectively, of the global burden of the disease and hold the 15th and the 18th positions in terms of incidence per 100,000 population. But India accounts for only about 5–6% of the world’s research output in this area and China a paltry 1% as seen from papers indexed in three international databases, viz. PubMed, Science Citation Index and Biochemistry and Biophysics Citation Index over the ten-year period 1990–1999. Thus there is a tremendous mismatch between the share of the burden of the disease and share of research efforts. Is such mismatch acceptable? It raises the question ‘should resource-poor countries invest in research or should they depend on research performed elsewhere and invest their meagre resources predominantly in health-care measures?’ We argue that both India and China should invest much more in research than they do. We have also mapped TB research in the two countries and identified institutions and cities active in research, journals used to publish the findings, use of high impact journals, impact of their research as seen from citations received and extent of international collaboration. Although China performs much less research than India and its work is quoted much less often, it seems to have done far better than India in health-care delivery in TB. Perhaps the Chinese are better able to translate know-how into do-how than the Indians.

EPrint Type:Journal Article (Paginated)
Keywords:Published literature, Mapping TB research, Article distribution, Citation analysis, International collaboration
Subjects:Bibliometrics
Citation Analysis
ID Code:875
Deposited On:21 May 2005
Eprint Statistics:View statistics for this eprint
Tell A Colleague:Tell a colleague about it.

1. The Global Alliance for TB Drug Development, Press release datelined Brussels, 23 March 2001.

2. Glaser, N., GATE, 2000, 18, 8–10.

3. Frieden, T. R., Lerner, B. H. and Rutherford, B. R., Lancet, 2000, 355, 1088–1092.

4. Dye, C., Scheele, S., Dolin, P., Pathania, V. and Raviglione, M. C., J. Am. Med. Assoc., 1999, 282, 677–686.

5. Global Tuberculosis Control, WHO Report 2000, World Health Organization, Geneva, Switzerland, WHO/CDS/TB/2000.275, p. 4; 10.

6. Balasangameshwara, V. H., Status of Tuberculosis in India – 2000 (eds Nayak, R., Shaila, M. S. and Ramananda Rao, G.), Society for Innovation and Development, Indian Institute of Science, Bangalore, 2000, pp. 41–46.

7. ‘Virtual’ research group to focus on TB cure, item 56, SPIN, The Wellcome Trust, 2 April 2001, 497 (quoting Financial Times, 27 March 2001, p. 10).

8. The Global Alliance for TB Drug Development, Press release datelined Bangkok, 10 October 2000.

9. Global Forum for Health Research, The 10/90 Report on Health Research 2000.

10. Coe, G. A. and Banta, D., Int. J. Technol. Assess. Health Care, 1992, 8, 255–267.

11. De, S. N., Nature, 1959, 183, 1533–1534.

12. De, S. N. and Chatterjee, D. N., J. Pathol. Bacteriol., 1953, 66, 559–562.

13. De, S. N., Bhattacharya, K. and Sarkar, J. K., ibid, 1956, 71, 201–209.

14. Garfield, E., in Essays of an Information Scientist, Towards Scientography, 1986, vol. 9, pp. 103–111.

15. Curr. Sci., 1990, 59, 623–627.

16. Arunachalam, S., Curr. Sci., 1997, 72, 912–922.

17. Arunachalam, S., Natl. Med. J. India, 1998, 11, 27–34.

18. Geiter, L., Ending Neglect: The Elimination of Tuberculosis in the United States, Institute of Medicine, Washington DC, National Academy Press, 2000.

19. Brown, S., Statement made at a press conference held at Washington DC, 21 March 2001.

20. Orfinger, B., 23 March 2001, http://www.disasterrelief.org/Disasters/010322TBday/ accessed on 27 July 2001.

21. World Health Report 1999, World Health Organization, WHO, Geneva, Switzerland, 1999, p. 1.

22. Michaud, C. M., Murray, C. J. L. and Bloom, B. R., J. Am. Med. Assoc., 2001, 285, 535–539.

23. Paul Nunn, Annual forum 3, Geneva, June 1999, http://www.globalforumhealth.org/docs/forum3doc391.htm accessed on 26 June 2001.

24. WHO, http://www.who.int/tdr/diseases/tb/whyresearch.htm accessed on 27 March 2001.

25. Tuberculosis Prevention Trial, Madras, Indian J. Med. Res. (Suppl), 1980, 72, 1–74.

26. Tuberculosis Research Centre, ibid, 1999, 110, 56-69.

27. Ogden, J. and Porter, J., Dev. Res. Insights, December 1999, 32.

28. Giorgio Roscigno, Global alliance for TB Drug Development Address to the Asian R&D Coalition Conference, Penang, 2 May 2001; http://www.tballiance.org/pdf.speech/gr_ardc.pdf.

29. AstraZeneca press release 25 April 2001; http://www.astrazeneca.com/NewsSection/NewsReleases/press_release_138.html.

30. Arunachalam, S. and Gunasekaran, S., Curr. Sci., 2001, 82 (accepted for publication).

31. Arunachalam, S. and Gunasekaran, S., International Society for Health Research – Indian Section, Annual Conference 2002, Sri Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvanathapuram, 1–3 February 2002.

32. Global Tuberculosis Control, WHO Report 2001, World Health Organization, Geneva, Switzerland, WHO/CDS/TB/2001.287.

33. Arunachalam, S., in The Web of Knowledge – A Festschrift in Honor of Eugene Garfield (eds Cronin, B. and Atkins, H. B.), Information Today Inc. and The American Society for Information Science, Medford, NJ, USA, September 2000, pp. 215–231.

34. Arunachalam, S., Scientometrics, 2001, 52, 235–259.

35. Acosta-Cazares, B., Browne, E., LaPorte, R. E., Neuvians, D., de Camargo, K. R., Tapia-Conyer, R. and Yang Ze., Scientific colonialism and safari research, Clinmed/2000010008.

36. Butler, D., Nature, 2000, 403, 692.

37. WHO press release dated 9 July 2001; http://www.who.int/infpr-2001/en/pr2001-32.html

38. Rowson, M., Br. Med. J., 2001, 323, 186.

39. Oxfam Report, See Financial Times, London, 19 July 2001, p. 12, and SPIN, The Wellcome Trust, 23 July 2001, 513, p. 7, item 45.

40. Hopes for Public Private Genome Research, SPIN, The Wellcome Trust, 30 July 2001, 514, p. 6, item 40.

41. O’Brian, R. J. and Nunn, P. P., Am. J. Respir. Crit. Care Med., 2001, 163, 1055–1058.

42. NIAID Global Health Research Plan for HIV/AIDS, Malaria, and Tuberculosis, National Institute of Allergy and Infectious Diseases, 7 May 2001.

43. Sen, K. and Bonita, R., Lancet, 2000, 356, 577–582.

44. Collins, C. and Coates, T. J., Am. J. Public Health, 2000, 90, 1389–1390.

45. Hicks, E. K., Cabo, P. G. and Rikken, F., Knowledge Policy, 1993–1994, 6, 79–98.

46. The Global Impact of Drug Resistant Tuberculosis, Open Society Institute, Harvard Medical School, 1999.

EPrints dLIST, an open access archive for the Information Sciences, is supported by the School of Information Resources and Library Science and Learning Technologies Center, University of Arizona. Established in 2002, dLIST has a global Advisory Board and is a part of the Information Technology & Society Research Lab. Open Archives
Contact: Admin | Donate